HIV Infections
Conditions
Brief summary
Prevalence of Sexually Transmitted Infections (STIs) and co-infections in the general population
Interventions
DIAGNOSTIC_TESTBlood sample
Blood sample
Sponsors
CerbaXpert
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject, male or female, 18 years of age or older * Subject capable of understanding the purpose of the research having given their free and informed written consent * Subject presenting to the laboratory for a biological examination * Affiliated subject or beneficiary of a social security scheme
Exclusion criteria
\- Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of each STI will be assessed by the participant's positive or negative status for each pathogen, determined by the following screening tests: | 3 years | HIV testing is based on finding antibodies to HIV-1 and HIV-2 and P24 antigen of the virus; * Hepatitis B screening is based on HBsAg (hepatitis B surface antigen) research; * Herpes screening is based on testing for antibodies to Herpes Simplex virus (HSV-1 and HSV-2); * Papilloma virus screening is based on the HPV-HR test from a smear on the cervix; * Chlamydia screening is based on a nucleic acid amplification (NAAT) test; * Gonorrhea screening is based on the identification of the bacteria on a urine sample or secretions from the vagina or cervix; * Screening for trichomoniasis is based on a molecular diagnosis that involves identifying the parasite's DNA from a genital or urinary sample; * The detection of syphilis is based on antibody research. |
Outcome results
None listed